Global Medtech Guidance Tracker: March 2020
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.
You may also be interested in...
UK MHRA To Medtech: Check Before Applying For Non-COVID-19 Trials
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.
European Commission Churns Out EU MDR Documents, Including On ‘Significant Changes’
The European Commission has reiterated that the MDR deadline of 26 May will go ahead despite the COVID-19 crisis, further hampering notified body resources and audit freedoms. It has put its foot on the accelerator by issuing seven new documents.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.